{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:28:39Z","timestamp":1787020119054,"version":"build-2736575974"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010083","name":"Hunan Provincial Innovation Foundation for Postgraduate","doi-asserted-by":"crossref","award":["CX20190156"],"award-info":[{"award-number":["CX20190156"]}],"id":[{"id":"10.13039\/501100010083","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early identification of congenital heart disease (CHD) allows detection of the pulmonary arteriopathy in an early stage, and timely shunt closure can permanently reverse pulmonary arterial hypertension (PAH). However, surgical correction is not recommended in patients with irreversible PAH. Herein we report our experience about Eisenmenger\u2019s syndrome in simple CHD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>From January 2017 to November 2018, a total of 8 CHD patients (3 ventricular septal defects (VSD), 2 atrial septal defects (ASD), and 3 patent ductus arteriosus (PDA), median age, 15.5\u2009years [range, 3\u201318\u2009years]) with PAH were detected by chest X-ray, electrocardiogram, transthoracic echocardiography (TTE), computed tomographic angiography (CTA) and cardiac catheterization. The median defect diameter, pulmonary artery pressure (PAP), pulmonary vascular resistance (PVR) were 16.5\u2009mm (range, 3\u201330\u2009mm), 75\u2009mmHg (range, 60\u201386\u2009mmHg), and 16 Woods units (range, 12\u201319 Woods units), respectively. Here, we report the representative cases of three types of simple CHD with irreversible PAH. The surgical correction was not performed in all patients who had fixed PAH and were referred to medical treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PAH in CHD can be reversed by early shunt closure, but this potential is lost beyond a certain point of no return. This article highlights the essence of enhancing the level of healthcare and services in Chinese rural areas. Failure to accurately and timely assess PAH will delay effective treatment past optimal treatment time, and even lead to death.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-020-01489-y","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:02:46Z","timestamp":1587600166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Image diagnosis: Eisenmenger\u2019s syndrome in patients with simple congenital heart disease"],"prefix":"10.1186","volume":"20","author":[{"given":"Haisong","family":"Bu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianli","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,23]]},"reference":[{"key":"1489_CR1","doi-asserted-by":"crossref","unstructured":"van der Feen DE, Bartelds B, de Boer RA, Berger R. Assessment of reversibility in pulmonary arterial hypertension and congenital heart disease. HEART 2018.","DOI":"10.1136\/heartjnl-2018-314025"},{"key":"1489_CR2","doi-asserted-by":"publisher","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","volume":"62","author":"MM Hoeper","year":"2013","unstructured":"Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;62:D42\u201350.","journal-title":"J Am Coll Cardiol"},{"key":"1489_CR3","doi-asserted-by":"crossref","unstructured":"Chen C, Luo F, Wu P, Huang Y, Das A, Chen S, et al. Metabolomics reveals metabolite changes of patients with pulmonary arterial hypertension in China. J Cell Mol Med. 2020.","DOI":"10.1111\/jcmm.14937"},{"key":"1489_CR4","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12887-019-1687-0","volume":"19","author":"H Bu","year":"2019","unstructured":"Bu H, Yang Y, Wu Q, Jin W, Zhao T. Echocardiography-guided percutaneous closure of perimembranous ventricular septal defects without arterial access and fluoroscopy. BMC Pediatr. 2019;19:302.","journal-title":"BMC Pediatr"},{"key":"1489_CR5","first-page":"3831","volume":"19","author":"H Bu","year":"2019","unstructured":"Bu H, Liu L, Hu S, Tan Z, Zhao T. Targeted nextgeneration sequencing for research and diagnostics in congenital heart disease, and cleft lip and\/or palate. Mol Med Rep. 2019;19:3831\u201340.","journal-title":"Mol Med Rep"},{"key":"1489_CR6","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S0022-5223(19)38415-6","volume":"87","author":"CA Wagenvoort","year":"1984","unstructured":"Wagenvoort CA, Wagenvoort N, Draulans-Noe Y. Reversibility of plexogenic pulmonary arteriopathy following banding of the pulmonary artery. J Thorac Cardiovasc Surg. 1984;87:876\u201386.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1489_CR7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ijcard.2014.04.072","volume":"174","author":"AC van Riel","year":"2014","unstructured":"van Riel AC, Schuuring MJ, van Hessen ID, Zwinderman AH, Cozijnsen L, Reichert CL, et al. Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification. Int J Cardiol. 2014;174:299\u2013305.","journal-title":"Int J Cardiol"},{"key":"1489_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","volume":"4","author":"MM Hoeper","year":"2016","unstructured":"Hoeper MM, Humbert M, Souza R, Idrees M, Kawut SM, Sliwa-Hahnle K, et al. A global view of pulmonary hypertension. Lancet Respir Med. 2016;4:306\u201322.","journal-title":"Lancet Respir Med"},{"key":"1489_CR9","doi-asserted-by":"publisher","first-page":"L1","DOI":"10.1152\/ajplung.00031.2013","volume":"305","author":"MG Dickinson","year":"2013","unstructured":"Dickinson MG, Bartelds B, Borgdorff MA, Berger RM. The role of disturbed blood flow in the development of pulmonary arterial hypertension: lessons from preclinical animal models. Am J Physiol Lung Cell Mol Physiol. 2013;305:L1\u2013L14.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1489_CR10","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1093\/eurheartj\/ehx034","volume":"38","author":"DE van der Feen","year":"2017","unstructured":"van der Feen DE, Bartelds B, de Boer RA, Berger R. Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease. Eur Heart J. 2017;38:2034\u201341.","journal-title":"Eur Heart J"},{"key":"1489_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1152\/physrev.00047.2009","volume":"91","author":"JJ Chiu","year":"2011","unstructured":"Chiu JJ, Chien S. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev. 2011;91:327\u201387.","journal-title":"Physiol Rev"},{"key":"1489_CR12","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.5603\/KP.2015.0242","volume":"73","author":"N Galie","year":"2015","unstructured":"Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Kardiol Pol. 2015;73:1127\u2013206.","journal-title":"Kardiol Pol"},{"key":"1489_CR13","unstructured":"Bu H, Gong X. Image diagnosis: an anomalous origin of right pulmonary artery from the ascending aorta. J Cardiovasc Comput Tomogr. 2018."},{"key":"1489_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/eurheartj\/ehv287","volume":"37","author":"C Fan","year":"2016","unstructured":"Fan C, Yang J. An inoperable aortic arch interruption in a patient with differential cyanosis. Eur Heart J. 2016;37:62.","journal-title":"Eur Heart J"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01489-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-020-01489-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01489-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T19:17:54Z","timestamp":1619119074000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-020-01489-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,23]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1489"],"URL":"https:\/\/doi.org\/10.1186\/s12872-020-01489-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,23]]},"assertion":[{"value":"13 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent to participate in the research was obtained from the patient\u2019s parents in the case of participants under the age of 16 to the use of his\/her all the related images and information for scientific purposes. The study was approved by the Committee on Clinical Trials and Applications at the Second Xiangya Hospital.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and clinical images was obtained from the patient\u2019s parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"194"}}